Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension-Reference-Cited by-同舟云学术

Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension

Published:2011-11-04 Issue:2 Volume:27 Page:210-215
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

De Backer Guy,Petrella Robert J.,Goudev Assen R.,Radaideh Ghazi A.,Rynkiewicz Andrzej,Pathak Atul

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2011.01006.x/fullpdf

Reference31 articles.

1. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur. Heart J.,2007

2. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002

3. Feasibility of treating prehypertension with an angiotensin-receptor blocker;Julius;N. Engl. J. Med.,2006

4. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham offspring study;Lieb;Circulation,2009

5. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension;SHEP Cooperative Research Group;JAMA,1991

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of natriuretic peptide clearance receptor mRNA in vascular smooth muscle cells by angiotensin II;Fundamental & Clinical Pharmacology;2015-03-31

2. Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2015-03

3. New Insights into the Management of Hypertension and Cardiovascular Risk with Angiotensin Receptor Blockers: Observational Studies Help Us?;The Open Cardiovascular Medicine Journal;2014-04-04

4. Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey;Vascular Health and Risk Management;2014-01

5. Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey;International Journal of Hypertension;2013